These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1932836)

  • 21. [Paradoxical effects of tamoxifen on the woman's uterus. Apropos of 7 cases of myoma that appeared while under anti-estrogen treatment].
    Boudouris O; Ferrand S; Guillet JL; Madelenat P
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(3):372-8. PubMed ID: 2738326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Duration of adjuvant treatment with tamoxifen in patients with resectable breast cancer].
    Davies C; Arriagada R; Ziegler A; Peralta O
    Rev Med Chil; 1998 Feb; 126(2):210-7. PubMed ID: 9659759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring of postmenopausal women treated with tamoxifen for breast carcinoma].
    Epifani S; Lattarulo S; Maiorino R; Fabiano G
    G Chir; 2000; 21(6-7):310-2. PubMed ID: 10916956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphologic endometrium changes with tamoxifen].
    Dallenbach-Hellweg G; Hahn U; Schmidt D
    Zentralbl Gynakol; 1996; 118(6):365-9. PubMed ID: 8768015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrotic syndrome and adjuvant treatment with tamoxifen for early breast cancer. Case report and review of the literature.
    Lauro S; Lalle M; D'Andrea MR; Vecchione A; Frati L
    Anticancer Res; 1994; 14(5B):2171-2. PubMed ID: 7840519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tamoxifen as systemic treatment of advanced breast cancer during pregnancy--case report and literature review.
    Isaacs RJ; Hunter W; Clark K
    Gynecol Oncol; 2001 Mar; 80(3):405-8. PubMed ID: 11263941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost effectiveness of tamoxifen in the prevention of breast cancer.
    Noe LL; Becker RV; Gradishar WJ; Gore M; Trotter JP
    Am J Manag Care; 1999 Jun; 5(6 Suppl):S389-406. PubMed ID: 10538851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal hyperlipaemia in a case of metastatic breast cancer treated by tamoxifen.
    Noguchi M; Taniya T; Tajiri K; Miwa K; Miyazaki I; Koshino H; Mabuchi H; Nonomura A
    Br J Surg; 1987 Jul; 74(7):586-7. PubMed ID: 3620865
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of visual function for patients on tamoxifen.
    Duchesne GM
    Clin Oncol (R Coll Radiol); 1993; 5(2):128. PubMed ID: 8481363
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical significance of tamoxifen withdrawal response.
    Canney PA; Griffiths T; Latief TN; Priestman TJ
    Lancet; 1987 Jan; 1(8523):36. PubMed ID: 2879105
    [No Abstract]   [Full Text] [Related]  

  • 34. The tamoxifen controversy.
    Crabbe WW
    Oncol Nurs Forum; 1996 Jun; 23(5):761-6. PubMed ID: 8792346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of tamoxifen on the female genital tract.
    Senkus-Konefka E; Konefka T; Jassem J
    Cancer Treat Rev; 2004 May; 30(3):291-301. PubMed ID: 15059652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer: can tamoxifen, under certain conditions, have adverse effects?].
    Cosset JM; Burtin P
    Bull Cancer; 1991; 78(8):685-6. PubMed ID: 1932836
    [No Abstract]   [Full Text] [Related]  

  • 38. Tamoxifen and ocular toxicity.
    Ah-Song R; Sasco AJ
    Cancer Detect Prev; 1997; 21(6):522-31. PubMed ID: 9398992
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.